What is new in Phoenix 8.5? On-Demand Webinar What is new in Phoenix 8.5? Discover the latest advancements and enhancements in Phoenix version 8.5. Watch the webinar to learn…CertaraFebruary 26, 2024
Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator Publication Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…CertaraFebruary 23, 2024
Streamlining Your NCA Workflow On-Demand Webinar Streamlining Your NCA Workflow PK analysis intended for submission contends with many data and compliance challenges. To work efficiently,…CertaraJanuary 18, 2024
Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome Publication Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…CertaraJune 28, 2023
Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program Case Study Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…CertaraJune 1, 2023
American College of Toxicology 2025 Annual Meeting Conference American College of Toxicology 2025 Annual Meeting – – BoothCertaraMay 24, 2023
Using Modeling & Simulation to Develop a Dosing Regimen for a Bispecific Antibody for Pediatric Cancer Case Study Using Modeling & Simulation to Develop a Dosing Regimen for a Bispecific Antibody for Pediatric Cancer Bispecific antibodies are an emerging class of antibodies developed in recent years that provide new…CertaraJanuary 23, 2023